Biotech Stocks Rise After Trump's Drug Price Risk Seems to Lessen

Biotech Stocks Rise After Trump's Drug Price Risk Seems to Lessen


President Donald Trump once said the drug industry was "getting away with murder," but Wall Street is betting that pharmaceutical companies could end up getting a relatively easy pass as the administration tackles rising drug prices. In the past week, news outlets have reported that an executive order the Trump administration is preparing will contain industry-friendly policies instead of more aggressive proposals.



from Biotech News